The EU's medicines watchdog said on Monday it had started reviewing an oral COVID medication from the US pharmaceutical firm Merck, raising hopes for an easy-to-administer treatment to reduce serious or deadly cases.
Oct 25, 2021
0
4
The EU's medicines watchdog could start a review within days of an oral COVID drug produced by the US pharmaceutical firm Merck, a senior official said Tuesday.
Oct 5, 2021
0
13
Merck will spend about $11.5 billion to buy Acceleron Pharma and its potential treatment for high blood pressure in vessels that connect the lungs and heart.
Sep 30, 2021
0
1
U.S. regulators have approved a new pneumonia vaccine from Merck, more than a month after OK'ing an improved version of rival Pfizer's shot.
Jul 17, 2021
0
4
Pharmaceutical giant Merck and an American laboratory reported promising results Saturday in trials of a drug administered orally to fight COVID-19, saying it helps reduce patients' viral load.
Mar 7, 2021
0
1023
Researchers from Regenstrief Institute, Indiana University School of Medicine and Merck & Co. created and validated a natural language processing (NLP) algorithm to identify patients with chronic cough. The validation paper, ...
Feb 9, 2021
0
8
Merck is giving up on two potential COVID-19 vaccines following poor results in early-stage studies.
Jan 25, 2021
0
9
Soaring sales of its cancer blockbuster and vaccines helped drive Merck's second-quarter profit up a whopping 54%, blowing past Wall Street expectations.
Jul 30, 2019
0
3
Surging sales of vaccines and the cancer immunotherapy drug Keytruda led to a quadrupling of profit at Merck during the first quarter as it blew past Wall Street expectations.
Apr 30, 2019
0
675
German pharmaceutical group Merck KgaA said Wednesday it had offered to buy electronics industry supplier Versum Materials for 5.3 billion euros ($6 billion), its biggest purchase in four years.
Feb 27, 2019
0
0
